Harvard Bioscience, Inc.
At Close: 4:00 PM
Harvard Bioscience, Inc.
HBIO Stock Price Today
Harvard Bioscience, Inc. (HBIO) stock rallied over 3.14% intraday to trade at $2.96 a share on NASDAQ. The stock opened with a gain of 0.70% at $2.89 and touched an intraday high of $3, rising 3.14% against the last close of $2.87. The Harvard Bioscience, Inc. in stock market went to a low of $2.83 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue$120.7 Million
5Y Sales Change2.60%
Fiscal Year EndsDec. 2021
IndustryLife Sciences Tools and Services
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Frequently Asked Questions
What is the current Harvard Bioscience, Inc. (HBIO) stock price?
Harvard Bioscience, Inc. (NASDAQ: HBIO) stock price is $2.96 in the last trading session. During the trading session, HBIO stock reached the peak price of $3 while $2.83 was the lowest point it dropped to. The percentage change in HBIO stock occurred in the recent session was 3.14% while the dollar amount for the price change in HBIO stock was $0.09.
HBIO's industry and sector of operation?
The NASDAQ listed HBIO is part of Life Sciences Tools and Services industry that operates in the broader Health Care sector. Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally.
Who are the executives of HBIO?
Mr. Jacques Coumans Ph.D.
Chief Marketing Officer
Mr. James W. Green
Pres, CEO & Chairman
Mr. Michael A. Rossi
Chief Financial Officer
Mr. Kenneth Fletcher Olson
How HBIO did perform over past 52-week?
HBIO's closing price is 0.49% higher than its 52-week low of $1.98 where as its distance from 52-week high of $6.49 is -0.54%.
How many employees does HBIO have?
Number of HBIO employees currently stands at 475. HBIO operates from 84 October Hill Road, Suite 10, Holliston, MA 01746, United States.
Link for HBIO official website?
Official Website of HBIO is: https://www.harvardbioscience.com
How do I contact HBIO?
How many shares of HBIO are traded daily?
HBIO stock volume for the day was 47,090 shares. The average number of HBIO shares traded daily for last 3 months was 141.08 Thousands.
What is the market cap of HBIO currently?
The market value of HBIO currently stands at $119.61 Million with its latest stock price at $2.96 and 41.64 Million of its shares outstanding.